Saturday, April 19, 2014

TearLab Q4 revenue jumps 176%

TearLab Q4 revenue jumps 176%

March 13, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported fourth quarter revenue of $4.4- million, up 176%, from $1.6-million for the same period in 2012. A total of 359 orders for TearLab systems were booked in the fourth quarter, of which 259 systems were under the company’s Masters Multi Unit Program, 72 were through its minimum use access […]

TearLab to acquire AOA’s OcuHub platform

TearLab to acquire AOA’s OcuHub platform

February 18, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has signed a non-binding term sheet to purchase the assets of the OcuHub business unit from AOAExcel, the for-profit subsidiary of the American Optometric Association (“AOA”). OcuHub, powered by AT&T and Covisint, is an established compliant technology platform designed to securely connect eye doctors, patients, healthcare organizations and payers. The acquisition […]

TearLab issues prelim Q4 revenue and gives 2014 revenue guidance

TearLab issues prelim Q4 revenue and gives 2014 revenue guidance

February 3, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) said preliminary total revenue for the fourth quarter of 2013 is expected to be about $4.5-million, bringing expected full year 2013 revenue to about $14.7-million.   The preliminary expected revenue in the fourth quarter reflects an increase of about 181%, compared with revenue of $1.6-million in the fourth quarter of 2012. The […]

In conversation with Elias Vamvakas

In conversation with Elias Vamvakas

January 28, 2014 by · Leave a Comment 

Tweet As CEO of San Diego-based TearLab (NASDAQ:TEAR; TSX:TLB), eye care entrepreneur, Elias Vamvakas, has scored another home run with a medical device for the diagnosis and management of dry eye disease (DED). The TearLab Osmolarity System uses a novel lab-on-a-chip approach that requires less than 50 nanoliters of tear fluid in order to measure […]

TearLab included in Feltl’s 2014 Top Idea List

TearLab included in Feltl’s 2014 Top Idea List

January 2, 2014 by · Leave a Comment 

Tweet Feltl & Co. has released its 2014 Top Idea List, which included TearLab (NASDAQ:TEAR; TSX:TLB). Analyst Ben Haynor writes that TearLab has first-mover advantage in point-of-care diagnostics for dry eye disease (DED). The TearLab Osmolarity System is a lab-on-a-chip system that provides a quantitative measure (osmolarity) of DED in less than 30 seconds. He […]

AOA goes to bat for TearLab test with private insurers

AOA goes to bat for TearLab test with private insurers

December 20, 2013 by · Leave a Comment 

http://www.youtube.com/watch?v=p24huh7sOpI&feature=c4-overview-vl&list=PL8GkKmXDug1dWbk6nDUxsQBnR-jEi1vtr’]

Tweet The Third Party Center of the American Optometric Association has worked with several state payers to establish a favorable coverage and reimbursement policy for the diagnosis of dry eye disease using the TearLab (NASDAQ:TEAR; TSX:TLB) Osmolarity Test. In late October, the center contacted the medical director of BlueCross BlueShield of Western New York (BCBSWNY) and BlueShield […]

TearLab osmolarity test in UK DED prevalence study

TearLab osmolarity test in UK DED prevalence study

December 17, 2013 by · Leave a Comment 

Tweet In collaboration with the UK’s National Health Service (NHS), four ophthalmologists are beginning a 1,000-patient multi-center study to assess the overall prevalence of dry eye disease (DED), using the TearLab (NASDAQ:TEAR; TSX:TLB) Osmolarity Test for the diagnosis of DED. Patients who suffer from a wide variety of eye complications presenting daily in NHS clinics […]

TearLab added to the MSCI US Small Cap Index

TearLab added to the MSCI US Small Cap Index

November 25, 2013 by · Leave a Comment 

Tweet As a result of the November 2013 semi-annual index review for the MSCI equity indices, TearLab (NASDAQ:TEAR; TSX:TLB) will be deleted from the MSCI US Micro Cap Index and added to the MSCI US Small Cap Index after stock market close on November 26. A summary of stock deletions and additions to the MSCI equity indices can […]

TearLab Q3 revenue jumps 247%

TearLab Q3 revenue jumps 247%

November 12, 2013 by · Leave a Comment 

Tweet Net revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 247% in the third quarter to $4.2-million from $1.2-million a year ago and was up 19% from $3.5-million in the second quarter this year. A total of 467 orders for TearLab Osmolarity systems were booked in the latest quarter.  That compares to 92 orders for TearLab systems […]

Alcon’s Seph Jensen joins TearLab as president & COO

Alcon’s Seph Jensen joins TearLab as president & COO

October 1, 2013 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has named Seph Jensen as president and COO. He joins TearLab from his current position as head of surgical marketing at Alcon Laboratories, having responsibility for more than $1.4-billion in revenue across its cataract, retina and refractive businesses. “Seph is a seasoned leader with a strong track record of delivering operational […]

Next Page »

Google+